Stress and the kidney

Advances in Chronic Kidney Disease

Volumn 22, Issue 1, 2015, Pages 46-53

  Bruce, Marino A ^a,b,c   Griffith, Derek M ^a,b,c   Thorpe, Roland J ^a,b,c  

^a JACKSON STATE UNIVERSITY   (United States)

^b Institute for Research on Men's Health   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Kidney disease; Minority health; Psychological stress; Social determinants of health; Socioeconomic factors

Indexed keywords

CHRONIC KIDNEY DISEASE; HUMAN; MENTAL STRESS; MINORITY HEALTH; PATHOPHYSIOLOGY; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SOCIAL DETERMINANTS OF HEALTH; SOCIOECONOMICS; AFRICAN AMERICAN; AGE; COMPLICATION; DISEASE COURSE; ECONOMICS; EPIDEMIOLOGY; ETHNOLOGY; PSYCHOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; DISEASE PROGRESSION; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 84920267966     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.06.008     Document Type: Review

References (138)

1. Harwood L., Wilson B., Sontrop J. Sociodemographic differences in stressful experience and coping amongst adults with chronic kidney disease. J Adv Nurs 2011, 67(8):1779-1789.
2. U.S. Renal Data System USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2011, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
3. Grams M.E., Coresh J., Segev D.L., Chow E.K.H. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 2013, 62(2):245-252.
4. Crook E.D., Patel S.R. Diabetic nephropathy in African-American patients. Curr Diab Rep 2004, 4(6):455-461.
5. Norris K., Nissenson A. Racial disparities in chronic kidney disease: tragedy, opportunity, or both?. Clin J Am Soc Nephrol 2008, 3(2):314-316.
6. Norris K., Nissenson A.R. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008, 19(7):1261-1270.
7. Powe N.R. To have and have not: health and health care disparities in chronic kidney disease. Kidney Int 2003, 64(2):763-772.
8. Martins D., Tareen N., Norris K. The epidemiology of end-stage renal disease among African Americans. Am J Med Sci 2002, 323(2):65-71.
9. Tareen N., Zadshir A., Martins D., Pan D., Nicholas S., Norris K. Chronic kidney disease in African American and Mexican American populations. Kidney Int 2005, 68(suppl 97):S137-S140.
10. Hsu C.-Y., Lin F., Vittinghoff E., Shlipak M.G. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003, 14(11):2902-2907.
11. Bruce M.A., Beech B.M., Crook E.D., et al. Association of socioeconomic status and CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis 2010, 55(6):1001-1008.
12. Bruce M.A., Beech B.M., Edwards C.L., et al. Weight status and high blood pressure among low-income African American men. Am J Mens Health 2011, 5(3):255-260.
13. Bruce M.A., Beech B.M., Sims M., et al. Social environmental stressors, psychological factors, and kidney disease. J Investig Med 2009, 57(4):583-589.
14. Crews D.C., Charles R.F., Evans M.K., Zonderman A.B., Powe N.R. Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis 2010, 55(6):992-1000.
15. Crews D.C., Pfaff T., Powe N.R. Socioeconomic factors and racial disparities in kidney disease outcomes. Semin Nephrol 2013, 33(5):468-475.
16. Merkin S.S., Coresh J., Roux Diez A.V., Taylor H.A., Powe N.R. Area socioeconomic status and progressive CKD: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2005, 46(2):203-213.
17. Plantinga L.C. Socio-economic impact in CKD. Nephrol Ther 2013, 9:1-7.
18. Shoham D.A., Vupputuri S., Diez Roux A.V., et al. Kidney disease in life-course socioeconomic context: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2007, 49(2):217-226.
19. Volkova N., McClellan W., Klein M., et al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008, 19(2):356-364.
20. Holmes T.H., Rahe R.H. The Social Readjustment Rating Scale. J Psychosom Res 1967, 11(2):213-218.
21. Thoits P.A. Stress, coping, and social support processes: where are we? What next?. J Health Soc Behav 1995, Spec no:53-79.
22. Cohen S., Kessler R.C., Gordon L.U. Personality characteristics as moderators of the relationship between stress and disorder. Measuring Stress: A Guide for Health and Social Scientists 1995, 3-26. Oxford University Press, New York, NY. S. Cohen, R.C. Kessler, L.U. Gordon (Eds.).
23. Selye H. The Stess of Life 1956, McGraw-Hill, New York, NY.
24. Everson-Rose S.A., Lewis T.T. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health 2005, 26:469-500.
25. Fremont A., Bird C. Social and psychological factors, physiological processes, and physical health. Handbook of Medical Sociology 2000, 334-352. Prentice Hall, Upper Saddle River, NJ. C. Bird, P. Conrad, A. Fremont (Eds.).
26. Theorell T., Kareseck R.A. Current issues in relating psychosocial job strain and cardiovascular disease research. J Occup Health Psychol 1996, 1(1):9-26.
27. Tsurugano S., Nakao M., Takeuchi T., Nomura K., Yano E. Job stress strengthens the link between metabolic risk factors and renal dysfunction in adult men. Tohoku J Exp Med 2012, 226(2):101-108.
28. Skinner E.A., Edge K., Altman J., Sherwood H. Searching for the structure of coping: a review and critique of category systems for classifying ways of coping. Psychol Bull 2003, 129(2):216-269.
29. Folkman S., Lazarus R.S., Gruen R.J., DeLongis A. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol 1986, 50(3):571-579.
30. Folkman S. Personal control and stress and coping processes: a theoretical analysis. J Pers Soc Psychol 1984, 46(4):839-852.
31. Williams D.R. The health of men: structured inequalities and opportunities. Am J Public Health 2003, 93(5):724-731.
32. Wenzel L., Glantz K., Lerman C. Stress, coping, and health behavior. Health Behavior and Health Education 2002, 201-239. John Wiley & Sons, San Francisco, CA. 3rd ed. K. Glantz, B.K. Rimer, F.M. Lewis (Eds.).
33. Glynn L.M., Christenfeld N., Gerin W. Recreating cardiovascular responses with rumination: the effects of a delay between harassment and its recall. Int J Psychophysiol 2007, 66(2):135-140.
34. Clark R., Benkert R.A., Flack J.M. Large arterial elasticity varies as a function of gender and racism-related vigilance in black youth. J Adolesc Health 2006, 39(4):562-569.
35. Harris C.W., Edwards J.L., Baruch A., et al. Effects of mental stress on brachial artery flow-mediated vasodilation in healthy normal individuals. Am Heart J 2000, 139(3):405-411.
36. Kop W.J., Verdino R.J., Gottdiener J.S., O'Leary S.T., Bairey Merz C.N., Krantz D.S. Changes in heart rate and heart rate variability before ambulatory ischemic events (1). J Am Coll Cardiol 2001, 38(3):742-749.
37. Kovach J.A., Nearing B.D., Verrier R.L. Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines. J Am Coll Cardiol 2001, 37(6):1719-1725.
38. Lind L., Johansson K., Hall J. The effects of mental stress and the cold pressure test on flow-mediated vasodilation. Blood Press 2002, 11(1):22-27.
39. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 2005, 30(1):1-10.
40. Williams J.E., Nieto F.J., Sanford C.P., Couper D.J., Tyroler H.A. The association between trait anger and incident stroke risk: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 2002, 30(1):13-19.
41. Williams J.E., Nieto F.J., Sanford C.P., Tyroler H.A. Effects of an angry temperament on coronary heart disease risk: the atherosclerosis risk in communities study. Am J Epidemiol 2001, 154(3):230-235.
42. Bhattacharyya M.R., Steptoe A. Emotional triggers of acute coronary syndromes: strength of evidence, biological processes, and clinical implications. Prog Cardiovasc Dis 2007, 49(5):353-365.
43. Spieker L.E., Hurlimann D., Ruschitzka F., et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 2002, 105(24):2817-2820.
44. DiBona G.F. Neural control of the kidney: past, present, and future. Hypertension 2003, 41(3 Pt 2):621-624.
45. Auchincloss A.H., Diez Roux A.V., Brown D.G., O'Meara E.S., Raghunathan T.E. Association of insulin resistance with distance to wealthy areas: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2007, 165(4):389-397.
46. Diez Roux A.V., Jacobs D.R., Kiefe C.I. Coronary artery risk developoment in young adults S. Neighborhood characteristics and components of the insulin resistance syndrome in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes Care 2002, 25(11):1976-1982.
47. Black P.H. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 2003, 17(5):350-364.
48. Barker D.J. Fetal origins of coronary heart disease. BMJ 1995, 311(6998):171-174.
49. Phillips D.I., Jones A., Goulden P.A. Birth weight, stress, and the metabolic syndrome in adult life. Ann N Y Acad Sci 2006, 1083:28-36.
50. Behar D.M., Rosset S., Tzur S., et al. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet 2010, 19(9):1816-1827.
51. Foster M.C., Coresh J., Fornage M., et al. APOL1 variants associate with increased risk of CKD among African Americans. J Am Soc Nephrol 2013, 24(9):1484-1491.
52. Freedman B.I., Kopp J.B., Langefeld C.D., et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010, 21(9):1422-1426.
53. Genovese G., Friedman D.J., Ross M.D., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329(5993):841-845.
54. Genovese G., Tonna S.J., Knob A.U., et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010, 78(7):698-704.
55. Hicks P.J., Staten J.L., Palmer N.D., et al. Association analysis of the ephrin-B2 gene in African-Americans with end-stage renal disease. Am J Nephrol 2008, 28(6):914-920.
56. Kao W.H., Klag M.J., Meoni L.A., et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008, 40(10):1185-1192.
57. Keene K.L., Mychaleckyj J.C., Leak T.S., et al. Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet 2008, 124(2):147-154.
58. Kopp J.B., Smith M.W., Nelson G.W., et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008, 40(10):1175-1184.
59. Lipkowitz M.S., Freedman B.I., Langefeld C.D., et al. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int 2013, 83(1):114-120.
60. Tzur S., Rosset S., Shemer R., et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010, 128(3):345-350.
61. Luft F.C. Renalase, a catecholamine-metabolizing hormone from the kidney. Cell Metab 2005, 1(6):358-360.
62. Xu J., Li G., Wang P., et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 2005, 115(5):1275-1280.
63. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150(9):604-612.
64. Szanton S.L., Thorpe R.J., Whitfield K. Life-course financial strain and health in African-Americans. Soc Sci Med 2010, 71(2):259-265.
65. Thorpe R.J., Kelly-Moore J. Life course theories of race disparities: a comparison of cumulative dis/advantage perspective and the weathering hypothesis. Race, Ethnicity, and Health 2013, 355-375. Jossey-Bass, San Francisco, CA. 2nd ed. T.A. LaVeist, L. Issac (Eds.).
66. Lohan M. How might we understand men's health better? Integrating explanations from critical studies on men and inequalities in health. Soc Sci Med 2007, 65(3):493-504.
67. Dannefer D. Cumulative advantage/disadvantage and the life course: cross-fertilizing age and social science theory. J Gerontol B Psychol Sci Soc Sci 2003, 58(6):S327-S337.
68. Ferraro K.F., Farmer M.M., Wybraniec J.A. Health trajectories: long-term dynamics among black and white adults. J Health Soc Behav 1997, 38(1):38-54.
69. Ferraro K.F., Kelley-Moore J.A. Cumulative disadvantage and health: long-term consequences of obesity?. Am Sociol Rev 2003, 68(5):707-729.
70. O'Rand A.M. The precious and the precocious: understanding cumulative disadvantage and cumulative advantage over the life course. Gerontologist 1996, 36(2):230-238.
71. Ferraro K.F. Health and aging. Handbook of Aging and the Social Sciences 2006, 238-256. Elsevier, Waltham, MA. 6th ed. R.H. Binstock, L.K. George (Eds.).
72. Preston S.H., Hill M.E., Drevenstedt G.L. Childhood conditions that predict survival to advanced ages among African-Americans. Soc Sci Med 1998, 47(9):1231-1246.
73. Geronimus A.T. The weathering hypothesis and the health of African-American women and infants: evidence and speculations. Ethn Dis 1992, 2(3):207-221.
74. Geronimus A.T., Bound J., Waidmann T.A., Colen C.G., Steffick D. Inequality in life expectancy, functional status, and active life expectancy across selected black and white populations in the United States. Demography 2001, 38(2):227-251.
75. Geronimus A.T., Bound J., Waidmann T.A., Hillemeier M.M., Burns P.B. Excess mortality among blacks and whites in the United States. N Engl J Med 1996, 335(21):1552-1558.
76. Williams D.R. Racism and health: a research agenda. Ethn Dis 1996, 6(1-2):1-8.
77. Williams D.R., Williams-Morris R. Racism and mental health: the African American experience. Ethn Health 2000, 5(3-4):243-268.
78. Iseki K., Iseki C., Ikemiya Y., Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996, 49(3):800-805.
79. Iseki K. Gender differences in chronic kidney disease. Kidney Int 2008, 74(4):415-417.
80. Carrero J.J. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 2010, 33(5):383-392.
81. Silbiger S., Neugarten J. Gender and human chronic renal disease. Gend Med 2008, 5(suppl A):S3-S10.
82. Robertson S. "I've been like a coiled spring this last week": embodied masculinity and health. Sociol Health Illn 2006, 28(4):433-456.
83. Creighton G., Oliffe J.L. Theorising masculinities and men's health: a brief history with a view to practice. Health Sociol 2010, 19(4):409-418.
84. Coles T. Negotiating the field of masculinity. Men Masc 2009, 12(1):30-44.
85. Courtenay W.H. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med 2000, 50(10):1385-1401.
86. Griffith D.M., Ellis K.R., Allen J.O. An intersectional approach to social determinants of stress for African American men: men's and women's perspectives. Am J Mens Health 2013, 7(suppl 4):19S-30S.
87. Hammond W.P. Taking it like a man: masculine role norms as moderators of the racial discrimination-depressive symptoms association among African American men. Am J Public Health 2012, 102(suppl 2):S232-S241.
88. Hooker S.P., Wilcox S., Burroughs E.L., Rheaume C.E., Courtenay W. The potential influence of masculine identity on health-improving behavior in midlife and older African American men. J Mens Health 2012, 9(2):79-88.
89. Mankowski E.S., Maton K.I. A community psychology of men and masculinity: historical and conceptual review. Am J Community Psychol 2010, 45(1-2):73-86.
90. Kershaw K., Rafferty J., Abdou C., Colbert S., Knight K., Jackson J.S. Chronic stress and the role of coping behaviors in health inequalities. Annu Rev Gerontol Geriatr 2009, 29(1):161.
91. McLeod J., Lively K. Social psychology and stress research. Mental Health, Social Mirror 2007, 275-303. Springer, NewYork, NY. J. McLeod, B. Pescosolido (Eds.).
92. Bruce M.A., Beech B.M., Crook E.D., et al. Sex, weight status, and chronic kidney disease among African Americans: the Jackson Heart Study. J Investig Med 2013, 61(4):701-707.
93. Evans J., Frank B., Oliffe J.L., Gregorty D. Health, illness, men, and masculinities (HIMM): a theoretical framework for understanding men and their health. J Mens Health 2011, 8(1):7-15.
94. Norris K., Mehrotra R., Nissenson A.R. Racial differences in mortality and ESRD. Am J Kidney Dis 2008, 52(2):205-208.
95. Tarver-Carr M.E., Powe N.R., Eberhardt M.S., et al. Excess risk of chronic kidney disease among African Americans versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol 2002, 13(9):2363-2370.
96. Williams D.R., Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep 2001, 116(5):404-416.
97. Sims M., Sims T.L., Bruce M.A. Race, ethnicity, concentrated poverty, and low birth weight disparities. J Natl Black Nurses Assoc 2008, 19(1):12-18.
98. Sims M., Sims T.L., Bruce M.A. Urban poverty and infant mortality rate disparities. J Natl Med Assoc 2007, 99(4):349-356.
99. Collins C.A. Racism and health: segregation and causes of death amenable to medical intervention in major U.S. cities. Ann N Y Acad Sci 1999, 896:396-398.
100. Rodriguez R.A., Sen S., Mehta K., Moody-Ayers S., Bacchetti P., O'Hare A.M. Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med 2007, 146(7):493-501.
101. Kawachi I., Daniels N., Robinson D.E. Health disparities by race and class: why both matter. Health Aff (Millwood) 2005, 24(2):343-352.
102. LaVeist T.A. Disentangling race and socioeconomic status: a key to understanding health inequalities. J Urban Health 2005, 82(2 suppl 3):iii26-iii34.
103. Williams D., Yu Y., Jackson J., Anderson N. Racial differences in physical and mental health: socioeconomic status, stress, and discrimination. J Health Psychol 1997, 2(3):335-351.
104. Krieger N. Does racism harm health? Did child abuse exist before 1962? On explicit questions, critical science, and current controversies: an ecosocial perspective. Am J Public Health 2003, 93(2):194-199.
105. Jones C. The impact of racism on health. Ethn Dis 2002, 12(1):S2. S10-S13.
106. Jones C. Levels of racism: a theoretic framework and a Gardener's tale. Am J Public Health 2000, 90(8):1212-1215.
107. Feagin J.R., Sikes M.P. Living with Racism: The Black Middle Class Experience 1994, Beacon, Boston, MA.
108. Feagin J.R. The continuing significance of race: antiblack discrimination in public places. Am Sociol Rev 1991, 56(1):101-116.
109. Wyatt S.B., Williams D.R., Calvin R., Henderson F.C., Walker E.R., Winters K. Racism and cardiovascular disease in African Americans. Am J Med Sci 2003, 325(6):315-331.
110. Williams D.R., Neighbors H.W. Racism, discrimination and hypertension: evidence and needed research. Ethn Dis 2001, 2001(11):800-816.
111. McNeilly M.D., Anderson N.B., Armstead C.A., et al. The Perceived Racism Scale: a multidimensional assessment of the experience of white racism among African Americans. Ethn Dis 1996, 6(1-2):154-166.
112. Wilson W.J. The Truly Disadvantaged: The Inner City, the Underclass and Public Policy 1987, University of Chicago Press, Chicago, IL.
113. Massey D.S. Segregation and stratification. Du Bois Rev 2004, 1(1):7-25.
114. LaViest T.A., Wallace J.M. Health risk and inequitable distribution of liquor stores in African American neighborhoods. Soc Sci Med 2000, 51(4):613-617.
115. Guyll M., Matthews K.A., Bromberger J.T. Discrimination and unfair treatment: relationship of cardiovascular reactivity among African American and European women. Health Psychol 2001, 20(5):315-325.
116. Snow R.C. Sex, gender, and vulnerability. Glob Public Health 2008, 3(suppl 1):58-74.
117. Griffith D.M. An intersectional approach to men's health. J Mens Health 2012, 9(2):106-112.
118. McLeod J. The meanings of stress expanding the stress process model. Soc Ment Health 2012, 2(3):172-186.
119. Aldwin C. Stress, Coping, and Development: An Integrated Perspective 2007, The Guiford Press, New York, NY.
120. Pieterse A.L., Carter R.T. An examination of the relationship between general life stress, racism-related stress, and psychological health among black men. J Couns Psychol 2007, 54(1):101-109.
121. Treadwell H.M., Ro M. Poverty, race, and the invisible men. Am J Public Health 2003, 93(5):705-707.
122. Treadwell H.M., Young A.M., Rosenberg M.T. Want of a place to stand: social determinants and Men's health. J Mens Health 2012, 9(2):104-105.
123. Treadwell H.M., Braithwaite K. Men's health: a myth or a possibility. J Mens Health Gend 2005, 2(3):382-386.
124. Pease B. Racialised masculinities and the health of immigrant and refugee men. Men's Health: Body Identity, and Context 2009, John Wiley and Sons, Hobboken, NJ. A. Broom, P. Tovey (Eds.).
125. Young A.M. Poverty and men's health: global implications for policy and practice. J Mens Health 2009, 6(3):279.
126. Young A.M., Meryn S., Treadwell H.M. Poverty and men's health. J Mens Health 2008, 5(3):184-188.
127. Xanthos C., Treadwell H.M., Holdern K.B. Social determinants of health among African American men. J Mens Health 2010, 7(1):11-19.
128. Warner D.F., Brown T.H. Understanding how race/ethnicity and gender define age-trajectories of disability: an intersectionality approach. Soc Sci Med 2011, 72(8):1236-1248.
129. Kimmel P.L., Cohen S.D., Peterson R.A. Depression in patients with chronic renal disease: where are we going?. J Ren Nutr 2008, 18(1):99-103.
130. Jackson J.S., Knight K.M. Race and self-regulatory health behaviors: the role of the stress response and the HPA axis. Social Structure, Aging and Self-regulation in the Elderly 2006, 189-240. Springer, New York, NY. K.W. Schaie, L.L. Carstensten (Eds.).
131. Merritt M.M., Bennett G.G., Williams R.B., Sollers J.J., Thayer J.F. Low educational attainment, John Henryism, and cardiovascular reactivity to and recovery from personally relevant stress. Psychosom Med 2004, 66(1):49-55.
132. Turner R.J. Understanding health disparities: the promise of the stress process model. Advances in the Conceptualization of the Stress Process: Essays in Honor of Leonard I. Pearlin 2009, 3-21. Springer, New York, NY. W.R. Avison (Ed.).
133. Turner R.J., Avison W.R. Status variations in stress exposure: implications for the interpretation of research on race, socioeconomic status, and gender. J Health Soc Behav 2003, 44(4):488-505.
134. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002, 25(12):2165-2171. Diabetes Prevention Program Research Group.
135. Svetkey L.P., Ard J.D., Stevens V.J., et al. Predictors of long-term weight loss in adults with modest initial weight loss, by sex and race. Obesity (Silver Spring) 2012, 20(9):1820-1828.
136. Svetkey L.P., Erlinger T.P., Vollmer W.M., et al. Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age. J Hum Hypertens 2005, 19(1):21-31.
137. Svetkey L.P., Stevens V.J., Brantley P.J., et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008, 299(10):1139-1148.
138. West D.S., Elaine Prewitt T., Bursac Z., Felix H.C. Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program. Obesity (Silver Spring) 2008, 16(6):1413-1420.